The 2024 Responsible Business and Impact Report Shares How Gilead Sciences Is Driving Change

NORTHAMPTON, MA / ACCESS Newswire / May 13, 2025 / At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we're driving change and working toward our vision to create a healthier world for all people. https://www.gilead.com/company/annual-impact-reports

Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: [e-mail]

SOURCE: Gilead Sciences

View the original press release on ACCESS Newswire


The Gilead Sciences Stock at the time of publication of the news with a fall of -0,92 % to 92,74USD on Tradegate stock exchange (13. Mai 2025, 14:47 Uhr).

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 116,37$, was eine Steigerung von +5,00% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.

 

UBS

 

Alle Partner

Übernehmen

Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche

Werbung Disclaimer